All In Biotech

Drug Trial Radar · NCT06497556

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients With Previously Treated KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer

Last checked: Nov 19, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 338 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

338

Actual

Start

Sep 23, 2024

Primary completion

May 19, 2026

Study completion Nov 30, 2029

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
Collaborators
Chugai Pharmaceutical
First posted
Jul 11, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and efficacy of divarasib compared to locally approved KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung cancer (NSCLC).

Conditions

  • Non-Small Cell Lung Cancer
  • KRAS G12C Lung Cancer

Interventions

  • DivarasibDrug

    Divarasib will be administered orally QD

  • SotorasibDrug

    Sotorasib will be administered orally QD

  • AdagrasibDrug

    Adagrasib will be administred orally BID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS)Time frame: Up to approximately 4 years

Locations

151 sites in 26 countries. Site status is shown where the registry gives one.

  • Banner Health MD Anderson AZ

    Gilbert, Arizona

  • Los Angeles Cancer Network

    Los Angeles, California

  • UCLA Hematology / Oncology Clinic

    Los Angeles, California

  • University of California, San Francisco

    San Francisco, California

  • Yale Cancer Center

    New Haven, Connecticut

  • University of Miami

    Miami, Florida

  • Florida Cancer Specialists - North;725 6th Ave South (St. Petersburg)

    St. Petersburg, Florida

  • University of Chicago Medical Center

    Chicago, Illinois

  • New England Cancer Specialists

    Westbrook, Maine

  • Dana Farber Cancer Institute

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Cancer and Hematology Centers of Western Michigan

    Grand Rapids, Michigan

  • Minnesota Oncology Edina

    Edina, Minnesota

  • Columbia University Medical Center

    New York, New York

  • Taylor Cancer Research Center

    Maumee, Ohio

  • Oncology Associates of Oregon, P.C

    Eugene, Oregon

  • Oregon Health & Science University

    Portland, Oregon

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania

  • Allegheny Cancer Center

    Pittsburgh, Pennsylvania

  • Tennessee Oncology, PLLC - Chattanooga

    Chattanooga, Tennessee

  • Baptist Clinical Research Institute

    Memphis, Tennessee

  • Tennessee Oncology

    Nashville, Tennessee

  • JPS Health Network

    Fort Worth, Texas

  • MD Anderson Cancer Center

    Houston, Texas

  • Texas Oncology - Northeast Texas

    Longview, Texas

  • Hospital Britanico

    Buenos Aires, Argentina

  • Centro Oncologico Korben

    Ciudad Autonoma Buenos Aires, Argentina

  • Liverpool Hospital

    Liverpool, New South Wales, Australia

  • GenesisCare North Shore

    St Leonards, New South Wales, Australia

  • Sunshine Coast University Hospital

    Birtinya, Queensland, Australia

  • Lyell McEwin Hospital

    Elizabeth Vale, South Australia, Australia

  • Peter Maccallum Cancer Centre

    Melbourne, Victoria, Australia

  • Krankenhaus Nord - Klinik Floridsdorf

    Vienna, Austria

  • AZORG Campus Aalst-Moorselbaan

    Aalst, Belgium

  • UZ Brussel

    Brussels, Belgium

  • Cliniques Universitaires St-Luc

    Brussels, Belgium

  • UZ Antwerpen

    Edegem, Belgium

  • Jessa Zkh (Campus Virga Jesse)

    Hasselt, Belgium

  • CHU de Liège (Sart Tilman)

    Liège, Belgium

  • CHU UCL Mont-Godinne

    Mont-godinne, Belgium

Showing 40 of 151 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.